Allred Capital Management, LLC Astrazeneca PLC Transaction History

Allred Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $28,291 - $32,076	-448 Reduced 13.23%	2,938 $203,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $183,555 - $238,509	3,386 New	3,386 $229,000
Q2 2021 Aug 05, 2021	SELL	$48.42 - $60.18 $37,670 - $46,820	-778 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$47.16 - $54.44 $2,688 - $3,103	-57 Reduced 6.83%	778 $38,000
Q1 2020 Apr 17, 2020	SELL	$37.79 - $51.33 $831 - $1,129	-22 Reduced 2.57%	835 $37.3 Million
Q4 2019 Jan 13, 2020	BUY	$42.46 - $50.46 $36,388 - $43,244	857 New	857 $42,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Allred Capital Management, LLC with notifications on news.